LEXARIA BIOSCIENCE CORP (LEXX)

US52886N4060 - Common Stock

3.49  +0.4 (+12.94%)

After market: 3.38 -0.11 (-3.15%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-2-29)
2023
(2023-8-31)
2022
(2022-8-31)
2021
(2021-8-31)
2020
(2020-8-31)
Revenue
386.28K230.00K260.00K720.00K310.00K
Minority Interest Expense
28.91K50.00K110.00K160.00K150.00K
Cost Of Goods
14.82K30.00K70.00K180.00K100.00K
Gross Profit
371.46K190.00K180.00K550.00K220.00K
Operating Expenses
5.82M6.73M7.57M6.06M4.36M
Research and Development
2.96M3.67M1.84M1.26M390.00K
Selling, General, and Administrative Expenses
2.67M3.06M5.72M4.81M3.98M
Operating Income
-5.44M-6.53M-7.38M-5.52M-4.15M
Interest Income/Expense
N/A-180.00KN/A-170.00K-40.00K
Non Recurring Items
N/AN/AN/AN/A-10.00K
Income Before Taxes
-5.47M-6.71M-7.38M-5.69M-4.15M
Net Income
-5.44M-6.66M-7.27M-4.03M-3.93M
EBITDA
-5.29M-6.38M-7.28M-5.41M-4.04M
 
Per Share Data
EPS Diluted Total Ops
-0.71-1.01-1.24-0.91-1.41
Non GAAP EPS
-0.68N/AN/AN/AN/A
 
Statistics
Gross Profit Margin
96.16%82.61%69.23%76.39%70.97%
Profit Margin
-1408.01%-2895.65%-2796.15%-559.72%-1267.74%
Operating Profit Margin
-1407.56%-2839.13%-2838.46%-766.67%-1338.71%

All data in USD

Charts